MAP2K7 and breast carcinoma: Downregulation of pERK1/2 by treatment with MEK inhibitor or nitric oxide donor also increased Mule–Mcl-1 (Figure 6B, left panel) complex and caspase-3 activity in breast cancer cells, indicating induction of apoptosis (Figure 6C, right panel).